Pharmaceutical Industry has been outsourcing various processes to the global outsourcing players worldwide. Recently, there has been discussion going on worldwide on the cognitive automation of processes. There are various processes which in future would not be requiring manpower rather the worked would be processed through robotics. Earlier, it was predicted that the robotic technology will be growing with a growth rate above 10% till 2020, however the current growth rate would surpass the predictions.
Also See: HOW TO WIN CUSTOMERS WITH CHATBOTS?
WHAT ROBOTIC PROCESS AUTOMATION (RPA) IS ABOUT?
Robotic process automation (RPA) is more about the software containing a set of commands that communicate with the digital system which leads to perform or complete the back – office and repetitive process-oriented task more efficiently than human. Increase in demand of reliability and productivity in various sectors have led to the adoption and application of automation in the outsource industry. Many tasks which were performed repetitively are now been performed through the robotic process automation. Companies like IPSoft Inc. headquartered in USA and British start up Blue Prism Ltd has already started using software robots and humanoids for more than half the projects they undertake and by solving the technical glitches with much higher speeds than human engineers.
ROLE OF RPA IN PHARMA
Pharmaceutical sector has been working to close the gap between rising cost in different process and profits in an environment of increasing regulatory control and testing, they face challenges of securing approval and bringing new drugs to market which safety, efficacy and profitability. In order to address these challenges, pharmaceutical firms has been radically revaluating business and operational and implementing strategic business process outsourcing through contract research organization, contact manufacturing organization and consultant. The advent of Robotic process automation promises to change the game, by applying the “robots” to perform the high-volume, repeatable tasks which are presently handled by humans.
REAPING EFFICIENCIES WITH ROUTINE
Also, RPA would be providing a fast, secure and auditable way for sponsors and their outsourced partners to execute recurring and consistent processes such as entering data into statistical databases, checking data quality, monitoring protocol compliance and submitting data to regulators. In comparison to the traditional automation tools, the RPA can be implemented in very span of time. Industries such as insurance, financial services and other data-intensive sectors are showing increased interest in RPA. Since pharmaceutical contract manufacturer, research and consultants typically apply standard and consistent rules to nearly every process, these repeatable and consistent processes are prime candidates for RPA, which is ideally suited to any process that can be defined and consistently executed with minimal variation.
Today, many pharmaceutical processes are still people-intensive and require high volumes of staff to toggle between multiple systems and screens to achieve “last-mile�? integration. RPA’s capability to help ensure proof of compliance and the built-in scalability of digital automation code could significantly reduce the need for people-based process execution, and can improve speed, accuracy and compliance at a reduced cost.
Also See: THE RISE OF MACHINES-EVERYTHING YOU NEED TO KNOW ABOUT VIRTUAL DIGITAL ASSISTANTS
One key challenge RPA must address before being widely adopted in pharmaceutical enterprises is that of validation. In a regulated environment, any system that performs a decision-making function requires validation and solid change control. Specifically, any change requires re-validation to show that the system either interprets the input correctly and correctly executes the expected resulting action, or flags the transaction for human intervention.
While pharmaceutical innovation enables people to live longer and healthier lives, the innovation process is complicated by regulatory and reporting challenges. By helping to address some of the key administrative tasks, RPA is enabling pharma firms to focus on bringing safe and effective drugs to market at a lower cost.